Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.

Wang M, Salek D, Belada D, Song Y, Jurczak W, Kahl BS, Paludo J, Chu MP, Kryachok I, Fogliatto L, Cheah CY, Morawska M, Sancho JM, Li Y, Patti C, Forsyth C, Zhang J, Lesley R, Ramadan S, Rule S, Dreyling M, ECHO investigators, ECHO Investigators

Open source

DOI: 10.1200/jco-25-00690
Published: 2025 Jul 10
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-00690,
  title = {Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.},
  author = {Wang M and Salek D and Belada D and Song Y and Jurczak W and Kahl BS and Paludo J and Chu MP and Kryachok I and Fogliatto L and Cheah CY and Morawska M and Sancho JM and Li Y and Patti C and Forsyth C and Zhang J and Lesley R and Ramadan S and Rule S and Dreyling M and ECHO investigators and ECHO Investigators},
  year = {2025},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-25-00690},
  url = {https://doi.org/10.1200/jco-25-00690}
}

RIS

TY  - JOUR
TI  - Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.
AU  - Wang M
AU  - Salek D
AU  - Belada D
AU  - Song Y
AU  - Jurczak W
AU  - Kahl BS
AU  - Paludo J
AU  - Chu MP
AU  - Kryachok I
AU  - Fogliatto L
AU  - Cheah CY
AU  - Morawska M
AU  - Sancho JM
AU  - Li Y
AU  - Patti C
AU  - Forsyth C
AU  - Zhang J
AU  - Lesley R
AU  - Ramadan S
AU  - Rule S
AU  - Dreyling M
AU  - ECHO investigators
AU  - ECHO Investigators
PY  - 2025
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-25-00690
UR  - https://doi.org/10.1200/jco-25-00690
ER  -

APA

M, W., D, S., D, B., Y, S., W, J., BS, K., J, P., MP, C., I, K., L, F., CY, C., M, M., JM, S., Y, L., C, P., C, F., J, Z., R, L., S, R., S, R., M, D., investigators, E., & Investigators, E. (2025). Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-25-00690

Source records

pubmed · retrieved 2026-09-26T07:52:26.555Z